Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Anderson Diagnostics & Labs in Chennai partners with Manipal Academy of Higher Education to launch the MAHE-Anderson Centre of Excellence in Reproductive Genomics. This initiative aims to ...

The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

Global Nanopore Sequencing Market OverviewThe nanopore sequencing market is projected to grow at a CAGR of around 11% during the forecast period, driven by rising demand for real-time, portable DNA ...

A central challenge in relapsed/refractory follicular lymphoma is determining a treatment sequence that maximizes current ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...